Cipla gets nod to import Moderna's COVID-19 vaccine in India
  • 3 years ago
India's drug regulator DCGI has granted permission to Mumbai-based Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, officials said on Tuesday. Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik. Watch the video for more information.